The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular characteristics in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva— Randomized phase II study.
 
Olav Engebraaten
Research Funding - Roche (Inst)
 
Laxmi Silwal-Pandit
No Relationships to Disclose
 
Elen Kristine Moller
No Relationships to Disclose
 
Silje Nord
No Relationships to Disclose
 
Marit Krohn
No Relationships to Disclose
 
Hans Kristian Moen Vollan
No Relationships to Disclose
 
Hedda von der Lippe Gythfeldt
No Relationships to Disclose
 
Elin Borgen
No Relationships to Disclose
 
Oystein Garred
No Relationships to Disclose
 
Anne Fangberget
No Relationships to Disclose
 
Marit Muri Holmen
No Relationships to Disclose
 
Steinar Lundgren
No Relationships to Disclose
 
Erik Andreas Wist
Speakers' Bureau - Roche
 
Ole Christian Lingjaerde
No Relationships to Disclose
 
Bjorn Naume
Speakers' Bureau - Amgen; GlaxoSmithKline; Roche
 
Anne-Lise Borresen-Dale
No Relationships to Disclose